Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

Bibliographic Details
Main Authors: Bo Li, Xin Zhao, Lei Zhang, Wen Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
AKT1
DNA repair
bioinformatics
breast cancer
emodin
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.687841/full
id doaj-2c44bcba6489450bb75ed63f5f7788ed
record_format Article
spelling doaj-2c44bcba6489450bb75ed63f5f7788ed2021-06-02T14:55:54ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.687841687841Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to DoxorubicinBo Li0Xin Zhao1Lei Zhang2Wen Cheng3Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2021.687841/fullAKT1DNA repairbioinformaticsbreast canceremodin
collection DOAJ
language English
format Article
sources DOAJ
author Bo Li
Xin Zhao
Lei Zhang
Wen Cheng
spellingShingle Bo Li
Xin Zhao
Lei Zhang
Wen Cheng
Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
Frontiers in Oncology
AKT1
DNA repair
bioinformatics
breast cancer
emodin
author_facet Bo Li
Xin Zhao
Lei Zhang
Wen Cheng
author_sort Bo Li
title Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
title_short Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
title_full Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
title_fullStr Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
title_full_unstemmed Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
title_sort corrigendum: emodin interferes with akt1-mediated dna damage and decreases resistance of breast cancer cells to doxorubicin
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-06-01
topic AKT1
DNA repair
bioinformatics
breast cancer
emodin
url https://www.frontiersin.org/articles/10.3389/fonc.2021.687841/full
work_keys_str_mv AT boli corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin
AT xinzhao corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin
AT leizhang corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin
AT wencheng corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin
_version_ 1721403469244399616

Similar Items